| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Li,Rong-Zhou | Chairman | 6.14% | DEVE & JOAN HAPPY LIFE LIMITED |
| Zheng,Cheng-Tian | Director | 4.01% | DANIEL & JESSICA HAPPY LIFE LIMITED |
| Xu,Zhi-Cheng | Director | 4.01% | DANIEL & JESSICA HAPPY LIFE LIMITED |
| Lan,Zi-Xiang | Director | 4.62% | HONG YUAN INTERNATIONAL INVESTMENT CO., LTD. |
| Jiang,Zhen-Fu | Independent Director | 0.00% | |
| Cai,Yi-Fen | Independent Director | 0.00% | |
| Wu,Ming-Zheng | Independent Director | 0.00% |
Change Company Name to ZHONGYANG OPTOELECTRONICS CO., LTD. (FORMER NAME: ZHONGYANG OPTOELECTRONICS CO., LTD.)
2023/08/01
Change Company Name to Zhong Yang Technology Co., Ltd.
2023/08/01
Change Capital to 1,500,000,000
2023/08/01
Change Person in Charge to Li,Rong-Zhou
2023/08/01
Change Company Name to ZHONGYANG OPTOELECTRONICS CO., LTD. (FORMER NAME: ZHONGYANG OPTOELECTRONICS CO., LTD.)
2022/12/09
Change Company Name to Zhong Yang Technology Co., Ltd.
2022/12/09
Change Company Name to ZHONGYANG OPTOELECTRONICS CO., LTD. (FORMER NAME: ZHONGYANG OPTOELECTRONICS CO., LTD.)
2022/11/18
Change Company Name to Zhong Yang Technology Co., Ltd.
2022/11/18
Change Company Name to ZHONGYANG OPTOELECTRONICS CO., LTD. (FORMER NAME: ZHONGYANG OPTOELECTRONICS CO., LTD.)
2022/04/11
Change Company Name to Zhong Yang Technology Co., Ltd.
2022/04/11
Change Capital to 1,000,000,000
2019/08/02
Change Capital to 800,000,000
2017/05/18
Change Capital to 500,000,000
2016/10/05
Change Capital to 183,395,420
2016/06/02
Change Capital to 115,395,420
2016/03/08
Change Capital to 53,395,420
2015/10/14
Change Capital to 51,800,000
2015/05/12
Change Capital to 39,250,000
2015/03/18
Change Person in Charge to Zheng,Cheng-Tian
2015/03/18
Change Company Name to Zhong Yang Technology Co., Ltd.
2014/08/12
Change Person in Charge to Li,Rong-Zhou
2014/08/12
Change Capital to 33,250,000
2014/01/15
Change Capital to 25,000,000
2013/11/21
Change Capital to 20,000,000
2013/09/24
Change Capital to 15,550,000
2013/09/10
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 221,166 | 921,854 | 945,024 |
| Operating cost | 173,298 | 797,517 | 911,499 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 47,868 | 124,337 | 33,525 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 47,868 | 124,337 | 33,525 |
| Operating expenses | 85,985 | 324,641 | 314,505 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -38,117 | -200,304 | -280,980 |
| Non-operating income and expenses | -9,634 | 14,096 | 5,645 |
| Net profit (loss) before tax | -47,751 | -186,208 | -275,335 |
| Income tax expense (benefits) | 182 | 1,884 | -75 |
| Net profit (loss) of ongoing business for the current period | -47,933 | -188,092 | -275,260 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -47,933 | -188,092 | -275,260 |
| Other comprehensive profit (loss), net | 32,245 | 59,885 | -30,120 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -15,688 | -128,207 | -305,380 |
| Net profit (loss) attributable to owners of parent company | -47,933 | -173,630 | -259,722 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 0 | -14,462 | -15,538 |
| Comprehensive profit (loss) attributable to owners of parent company | -15,688 | -114,063 | -289,819 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 0 | -14,144 | -15,561 |
| Basic earnings per share (yuan) | 0 | -1 | -3 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -55,132 | -79,525 | 58,316 |
| Net cash inflows (outflows) from investing activities | -18,937 | -332,799 | -79,142 |
| Net cash inflow (outflow) from financing activities | -107,345 | -54,248 | -200,031 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 15,706 | 28,338 | -15,579 |
| Increase (decrease) in cash and cash equivalents in the current period | -165,708 | -438,234 | -236,436 |
| Beginning balance of cash and cash equivalents | 552,543 | 990,777 | 1,227,213 |
| Ending balance of cash and cash equivalents | 386,835 | 552,543 | 990,777 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,147,762 | 1,256,997 | 1,628,171 |
| Non-current asset | 2,293,671 | 2,268,902 | 2,060,696 |
| Total asset | 3,441,433 | 3,525,899 | 3,688,867 |
| Current liability | 664,431 | 727,414 | 1,247,657 |
| Non-current liability | 804,136 | 809,931 | 528,006 |
| Total liability | 1,468,567 | 1,537,345 | 1,775,663 |
| share capital | 967,561 | 967,561 | 912,129 |
| Equity - secruity token | - | - | - |
| capital reserve | 1,237,833 | 1,237,833 | 1,259,512 |
| retained earning | -258,337 | -210,404 | -259,722 |
| Other equity | 25,809 | -6,436 | -55,824 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,972,866 | 1,988,554 | 1,856,095 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 0 | 0 | 57,109 |
| Total Equity | 1,972,866 | 1,988,554 | 1,913,204 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 20 | 20 | 20 |
